Study on Onvansertib with Chemotherapy and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adults with KRAS or NRAS Mutation | Clinical Trial

Study on Onvansertib with Chemotherapy and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adults with KRAS or NRAS Mutation | Clinical Trial | Right2Hope